Cheers, yes I think you're right. They've consistently said this was off the main path so not much should be put on those results but any negativity I'm hoping to avoid as they're going to need to raise capital to get much happening in the clinic and I'd prefer that was at the highest possible share price. And it just looks terrible from an image perspective to push back a timeline again and again.
Overall the company has already been punished and the market cap is very low now. Positive phase one with promising efficacy signals will be what every share holder is hoping for!
NYR Price at posting:
8.4¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)